Increase of sentinel lymph node melanoma staging in The Netherlands; still room and need for further improvement

Eric A. Deckers, Marieke W. J. Louwman, Schelto Kruijff, Harald J. Hoekstra*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

36 Downloads (Pure)

Abstract

Aim: To investigate implementation of the seventh American Joint Committee on Cancer melanoma staging with sentinel lymph node biopsy (SLNB) and associations with socioeconomic status (SES). Patients & methods: Data from The Netherlands Cancer Registry on patient and tumor characteristics were analyzed for all stage IB-II melanoma cases diagnosed 2010-2016, along with SES data from The Netherlands Institute for Social Research. Results: The proportion of SLNB-staged patients increased from 40% to 65% (p <0.001). Multivariate analysis showed that being female, elderly, or having head-and-neck disease reduced the likelihood of SLNB staging. Conclusion: SLNB staging increased by 25% during the study period but lagged among elderly patients and those with head-and-neck melanoma. In The Netherlands, SES no longer affects SLNB staging performance.

Original languageEnglish
Pages (from-to)27-38
Number of pages12
JournalMelanoma management
Volume7
Issue number1
DOIs
Publication statusPublished - May-2020

Keywords

  • elderly
  • head and neck
  • melanoma
  • sentinel lymph node
  • socioeconomic status
  • staging
  • POPULATION-BASED ANALYSIS
  • QUALITY-OF-LIFE
  • CUTANEOUS MELANOMA
  • FOLLOW-UP
  • BIOPSY
  • MORBIDITY
  • DISSECTION
  • TRIAL
  • LYMPHADENECTOMY
  • AXILLARY

Cite this